Cortexyme's GAAP loss for 6M 2021 was $44.84 million, up 28.9% from $34.788 million in the prior year.
Cortexyme's GAAP loss for 6M 2021 was $44.84 million, up 28.9% from $34.788 million in the prior year.
Financial results
Cortexyme's GAAP loss for 6M 2021 was $44.84 million, up 28.9% from $34.788 million in the prior year. Source: 
ir.cortexyme.com
ir.cortexyme.com
English (US) 